Description of event:
International Conference and Exhibition on Pharmacovigilance and Clinical Trials
International Conference and Exhibition on Pharmacovigilance and
Clinical Trials during October 1-3, 2012 at DoubleTree by Hilton Chicago-North Shore, USA
Pharmacovigilance-2012 is a remarkable event which brings together a unique and International mix of large and
medium Clinical Research Organizations,
Pharmaceutical companies, leading universities and institutes.
Making the Congress a perfect platform to share experience, foster collaborations across industry and academia and share emerging technologies across the globe by means of
Clinical Trials, Regulatory efforts of industrial technology. Initiation of cross-border co-operations between scientists and institutions will be also facilitated.
Pharmacovigilance-2012 will schedule and coordinate all meetings with our Editorial Board Members and other experts in the pharma field across the World.
The scientific program paves a way to gather visionaries through the research talks and presentations and put forward many thought provoking strategies in Pharmacovigilance and
Clinical Trials. The scientific program will
focus on
current advances in the
clinical research and advances in pharmacovigilance with a
focus on Safer
Drugs and
Good Clinical Practice.
Conference Highlights the following topics:
• Pharmacovigilance and its Challenges
• Role of
Clinical Trials
•
Clinical Trials on Diseases
• Adverse
Drug Reactions
•
Drug Interactions
• Pharmacy Practices & its Challenges
• Regulatory Affairs
• Risk
Management: New Approaching Paradigm for Phrmacovigilance
•
Clinical Research and Statistics
• Strategies for Growth in Pharma Environment
International Conference and Exhibition on Pharmacovigilance and
Clinical Trials, having the theme "Safer
Drugs and
Good Clinical Practice."
Pharmacovigilance-2012 is comprised of 10 tracks and 43 sessions designed to offer comprehensive sessions that address
current issues in Pharmacovigilance and
Clinical Trials.
Pharmacovigilance and its Challenges
Track 1-1 Role of pharmacovigilance in health regulation
Track 1-2 International collaboration for pharmacovigilance
Track 1-3 Role of pharma industries in the improvement of pharmacovigilance system
Track 1-4 Fatality of pharmacovigilance failure
Track 1-5 Detection & evaluation of
drug safety
signals
Track 2: Role of
Clinical Trials
Track 2-1
Data collection and
quality control
Track 2-2 Alternative trials design and models
Track 2-3 Multi center trials and monitoring
Track 2-4 Practice of good and ethical
clinical trials
Track 3:
Clinical Trials on Diseases
Track 3-1 Recent
clinical trials on
Alzheimer's disease
Track 3-2 Recent
clinical trials on Parkinson’s
disease
Track 3-3
Clinical trials on
cancer
Track 3-4 Applications of
biomarkers in
clinical trials
Track 3-5 Emerging technology in
clinical trials
Track 4: Adverse
Drug Reactions
Track 4-1 Assessing & reporting adverse
drug reactions
Track 4-2 Reduction of adverse
drug reaction by nano technology
Track 4-3 Expected and un-expected
drug reactions and its reporting
Track 4-4
Drugs in human pregnancy and nursing
Track 4-5 Pharmacotherapy and
Pharmacogenomics
Track 4-6 Post marketing reports on adverse effects
Track 5:
Drug Interactions
Track 5-1 Advances of pharmacokinetic
interactions
Track 5-2 Advances of pharmacodynamic
interactions
Track 5-3
Drug and substance abuse
Track 5-4
Drug-
drug interactions
Track 5-5 Pharmacoenvironmentology
Track 6: Pharmacy Practices and Its Challenges
Track 6-1 Pharmacy practice and its guidelines
Track 6-2 Challenges in compounding and dispensing practice
Track 6-3
Drug toxicity and
drug safety measures
Track 6-4 pharmacoepidemiology of
drug shortages
Track 7: Regulatory Affairs
Track 7-1 Role of regulatory affairs in pharmacovigilance
Track 7-2 Role of regulatory agencies in safe medicines and medical devices
Track 7-3 Risk minimization tools
Track 8: Risk
Management: New Approaching Paradigm for Pharmacovigilance
Track 8-1 Information technology in Pharmacovigilance and promoting companies
Track 8-2 Review of
software’s used in pharmacovigilance and
clinical trials
Track 8-3 Risk communication: Interface between pharmacovigilance, sales and marketing
Track 8-4 Risk
management versus recent market withdrawal
Track 8-5 Monitoring unlicensed, off
labels and orphan
drugs
Venue:
DoubleTree by Hilton Hotel Chicago - North Shore
9599 Skokie Blvd Skokie,
Chicago, Illinois, United States-60077
Contact us:
Conference Secretariat: Pharmacovigilance-2012,
OMICS Group Conferences
5716 Corsa Ave., Suite 110,
Westlake, Los Angeles,
CA 91362-7354, USA